via University of Oxford
A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms.
A University of Oxford study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, outlines a new type of blood test that can be used to detect a range of cancers and whether these cancers have spread (metastasised) in the body.
The study analysed samples from 300 patients with non-specific but concerning symptoms of cancer, such as fatigue and weight loss, who were recruited through the Oxfordshire Suspected CANcer (SCAN) pathway.
The researchers assessed whether the test could distinguish patients with a range of solid tumours from those without cancer. Their results show that cancer was correctly detected in 19 out of every 20 patients with cancer using this test. In those with cancer, metastatic disease was identified with an overall accuracy of 94%. These results make this the first technology to be able to determine the metastatic status of a cancer from a simple blood test, without prior knowledge of the primary cancer type.
This test shows promise to help clinicians detect cancer and assess cancer stage in the future. Unlike many blood-based tests for cancer, which detect genetic material from tumours, this test uses a technique called NMR metabolomics, which uses high magnetic fields and radio waves to profile levels of natural chemicals (metabolites) in the blood.
Healthy individuals, people with localised cancer, and people with metastatic cancer each have different profiles of blood metabolites, which can be detected and then analysed by the researchers’ algorithms to distinguish between these states.
Dr James Larkin, researcher on the study from the University of Oxford, says: ‘Cancer cells have unique metabolomic fingerprints due to their different metabolic processes. We are only now starting to understand how metabolites produced by tumours can be used as biomarkers to accurately detect cancer. We have already demonstrated that this technology can successfully identify if patients with multiple sclerosis are progressing to the later stages of disease, even before trained clinicians could tell. It is very exciting that the same technology is now showing promise in other diseases, like cancer.’
Cancers detected earlier are more likely to be treated successfully. This rapid and inexpensive test could help to overcome many barriers to the early detection of cancer, especially in patients that present with non-specific symptoms, which do not direct investigations towards a specific organ. NHS Rapid Diagnostic Centres, similar to Oxfordshire’s SCAN pathway, are currently being set up across the NHS to support faster and earlier cancer diagnosis in all patients with symptoms that could indicate cancer.
This new test is not specific to a single cancer type and has shown promise in this traditionally challenging clinical context, including the potential to detect some cancers in the community before conventional imaging is performed.
Dr Fay Probert, lead researcher of the study from the University of Oxford, says: ‘This work describes a new way of identifying cancer. The goal is to produce a test for cancer that any GP can request. We envisage that metabolomic analysis of the blood will allow accurate, timely and cost-effective triaging of patients with suspected cancer, and could allow better prioritisation of patients based on the additional early information this test provides on their disease.’
Future studies with larger patient cohorts will further evaluate this technique for the earlier detection of new cancers and potential clinical applications.
Original Article: New test can identify if a patient has cancer and if it has spread
More from: University of Oxford
The Latest on: Cancer blood test
- Researchers offer solution to help tackle patient backlog in the NHS bowel cancer screening programon August 17, 2022 at 11:22 am
In England, 37 people die each day from bowel cancer, but screening using fecal blood testing followed by a colonoscopy can reduce both the incidence of this cancer and the number of resulting deaths.
- When should I get a COVID booster? Next-generation antibody tests could helpon August 17, 2022 at 10:20 am
Since late last year, federal officials have been asking, practically begging people to get booster doses of the COVID-19 vaccine. But more than half of Americans have ignored the request even for a ...
- Everyone 58 and over in England to be sent free bowel cancer home test kits by NHSon August 17, 2022 at 8:29 am
Bowel cancer awareness is at an all-time high due to the work of Dame Deborah James. Now, the NHS are sending all over-58s a test they can take at home to test for the disease.
- Dad With 'No Signs' of Cancer Given Weeks to Live on Baby's First Birthdayon August 17, 2022 at 7:03 am
A dad diagnosed with terminal cancer on his daughter's first birthday plans to battle his disease to allow him to spend as much time as possible with his family. Dean Whelan, from Golcar in northern ...
- Prostate cancer screening: Should you get a PSA test?on August 16, 2022 at 5:07 am
Learn about the pros and cons of the PSA test so you're ready to talk about prostate cancer screening with your doctor.
- Cancer Test Kit Market Size and Growth 2022 Analysis Report by Development Plans, Manufactures, Latest Innovations and Forecast to 2028on August 16, 2022 at 1:40 am
Aug 16, 2022 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Cancer Test Kit Market” ...
- Treating cancer with a simple blood teston August 15, 2022 at 11:28 am
The test is based on cancer cells circulating in the blood flow and, as such, should be conducted before commencing treatment that reduces the scope of cancer cells.
- Brave dad refused to leave A&E without blood test - results show he has terminal canceron August 13, 2022 at 3:08 am
They basically told me there was nothing wrong with me. I wasn’t going to sit there for hours to be told nothing was wrong.” ...
- If You Were Born Before This Year, Get a Blood Test, CDC Sayson August 12, 2022 at 4:33 am
Knowing the risk factors for health conditions can help you determine whether or not you need to be screened for them—and when it comes to one particular illness, one of the biggest risk factors is ...
- City of Hope Researchers Have Developed a Blood Test That May Screen for Early-onset Colorectal Canceron August 10, 2022 at 7:00 am
Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States, may ...
via Bing News
The Latest on: Cancer blood test
via Google News